374 Subject Index
neuropeptide Y 51– 2, 235
neurotic symptoms 231, 232
neurotransmitters 51– 2, 55, 162,
235–6
New Deal programs (US) 9
newspapers 83, 106
NHS Centre for Reviews and
Dissemination 185
NHS Review 203
nicotine 52 – 3, 54
nonfood, food and 64
noradronergic pathway 195
norepinephrine (NE) 51, 235
novelty /novel foods 34, 35, 46
obesity 1, 2, 4, 128, 279
appetite regulation 160 –1
behavioral theories 164 – 9
Body Mass Index 149, 150
causes 157 – 77, 179
consequences 152 – 7
defined 148 – 50
dietary restraint and 142
dieting 141
eating behavior 168 – 76
evolutionary model 162 – 3
fat cell theory 160, 179
genetic theories 157 – 8, 160 –1, 179,
279
measurement 149 – 50
metabolic rate theory 159 – 60, 179
negative aspects 89 – 90, 95 – 6
neural model 162
obesogenic environment 163 – 77
percentage body fat 149 – 50
physical activity and 164 – 9
physical problems 152 – 4, 179
population means 148 – 9
prevalence 151– 2
problems with research 177 – 9
psychological problems 154 – 7, 179
rates of 151– 2, 179
stereotypes 89 – 90, 95
waist circumference 149
obesity treatment 4, 140, 141, 279
alternatives 190 – 201, 210
at-risk children 208 – 9
benefits 190, 209 –10
contemporary specific approaches
183
costs 187 – 90, 209
dietary intervention 182 – 7
doctors’ beliefs 180 – 2, 209
drugs 181, 194 – 6, 199 – 200, 201, 210
exercise-based 191– 4, 207, 209, 210
help-seeking behavior 203
historical factors 202 – 3
individualistic approaches 207 – 9
multidimensional behavioral
programs 183 – 5
necessity of 187 – 90
nonpsychological intervention
199 – 201
physical problems 188 – 90, 209
pregnancy and 207 – 8
prevention and 206 – 9
problems with weighing 185 – 7
profile characteristics 202
psychological factors 188, 203 – 4,
209
public health intervention 206 – 7,
210
success stories 201– 6
surgical 196 – 9, 199 – 200, 201, 210
traditional approaches 182
obesogenic environment 163 – 77
object relations 255 – 6
objectification (of women) 119
observational method 29 – 30
obsessive compulsive disorder 216,
224, 235
omnivore’s paradox 34
operant conditioning 39, 238
orlistat 195 – 6